@GaryBird18 Easiest thing to do when ‘playing safe’ is to sell 50-80% of your $ITRM stock at break even, and let the rest roll for a gamble play. Nobody knows if it’ll get approved so it’s pretty much gamble mode on.
@Noemileone7 25th July is the deadline for rejection or approval. The other option is that the approval is ‘delayed’ which means it’s pushed to a later date to allow more time for FDA to review. Usually a delay = drop in stock.
$CBLI
clip from the recent PR they are addressing a total of $340,000,000,000 in markets!
And their market cap is only $67 million. Expecting a double on next PR, float is 7.7M and they are positioned for huge growth... https://t.co/CKG0fOZvpj